• Journal of Preventive Medicine and Public Health
• /
• 제50권4호
• /
• pp.262-267
• /
• 2017

Objectives: The US ranks ninth in obesity in the world, and approximately 7% of US adults experience major depressive disorder. Social isolation due to the stigma attached to obesity might trigger depression. Methods: This paper examined the impact of obesity on depression. To overcome the endogeneity problem, we constructed pseudopanel data using the Behavioral Risk Factor Surveillance System from 1997 to 2008. Results: The results were robust, and body mass index (BMI) was found to have a positive effect on depression days and the percentage of depressed individuals in the population. Conclusions: We attempted to overcome the endogeneity problem by using a pseudo-panel approach and found that increases in the BMI increased depression days (or being depressed) to a statistically significant extent, with a large effect size.

• 생물정신의학
• /
• 제23권1호
• /
• pp.1-11
• /
• 2016

Development of various antidepressants such as monoamine oxidase inhibitors, tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and noradrenergic and specific serotonergic antidepressant has led to a tremendous progression of pharmaceutical treatment for depression, but still there are some limitations of current antidepressants, such as treatment-resistant depression and delayed onset of antidepressants. The pathogenesis of depression is unclear because depression is a heterogeneous disease state, and the mechanisms of antidepressants remain uncertain as well. Nevertheless, in an attempt to develop novel antidepressants, some trials have been conducted based on the potential biological mechanism discovered in the numerous research results. This review will provide information about the potential novel antidepressants and the current states of clinical studies using them. In particular, some potential novel antidepressants anti-inflammatory agents, antioxidants, anticholinergics, modulators of Hypothalamic Pituitary Adrenal Axis, glutamate, and opioid systems, as well as some neuropeptides such as susbstance P, neuropeptide Y, and galanin will be discussed.

• Perspectives in Nursing Science
• /
• 제13권1호
• /
• pp.10-16
• /
• 2016

Purpose: This study aimed to investigate differences in drinking scores according to stress and depression. Methods: A secondary analysis of the 5th and 6th Korea National Health and Nutrition Examination Surveys was conducted. Complex sampling design data analysis was performed in order to identify differences in Alcohol Use Disorder Identification Test (AUDIT) scores according to stress and depression among 1,732 unmarried women. Results: The average AUDIT score was 6.14 in unmarried women. There were significant differences in AUDIT scores in terms of stress and depression. Conclusion: Practical programs that can prevent alcohol drinking for unmarried women are suggested. Programs for alcohol-related problems should include stress and depression management.

• 수면정신생리
• /
• 제12권1호
• /
• pp.50-57
• /
• 2005

목 적：본 연구에서는 주요우울장애를 동반한 공황장애 환자들과 동반하지 않은 공황장애 환자들을 대상으로, 환자들이 경험하는 공황장애의 임상 양상 및 증상의 심각도의 차이를 확인하고, 주관적인 증상 평가 이외에 불안을 나타내는 생리적 지표인 자율신경계 기능의 차이도 함께 알아보고자 하였다. 방 법：DSM-IV 진단 기준으로 공황장애 환자들에서 주요우울장애가 공존하는 것으로 진단된 19명과 주요우울장애가 공존하지 않는 것으로 진단된 60명을 대상으로 첫 외래 방문시 공황 증상으로 인한 고통 정도와 회피 정도를 측정하는 기본 기록지와 기타 자기 보고식 설문지를 실시하였으며, 자율 신경계 기능을 평가하기 위해서 객관적, 생리적 지표로 Heart Rate Variability(HRV)를 측정하고 환자들이 경험하는 공황장애의 심각성을 평가하기 위해 임상가들에 의해 Clinical Global Impression(CGI)과 Panic Disorder Severity Scale(PDSS)을 시행하여 객관적으로 평정하였다. 자료 분석을 위해 환자들이 보고한 각 임상 척도 점수 및 임상가 평정 점수를 주요우울장애가 공존하는 공황장애 환자군과 그렇지 않은 공황장애 환자군에 따라 t-test를 통해 비교하고, 두 집단간 HRV 양상을 비교하기 위해서 연령을 공변인으로 설정하고 ANCOVA를 실시하였다. 결 과：주요우울장애가 동반된 공황장애 환자들은 공황장애로만 진단된 환자들에 비해 주관적으로 호소하는 우울이나 불안 수준이 더 높았으며, 불안 민감도나 신체 증상에 대한 예민성도 더 많이 호소하는 경향이 있었다. 또한 부정적인 일상생활에서 자신을 비하하고 낙담하게 하는 부정적인 자동적 사고 경향이 더 높았으며, 자기 자신을 고양하고 미래를 희망적으로 지각하는 긍정적인 자동적 사고 경향은 더 낮은 것으로 나타났다. CGI와 PDSS와 같은 객관적 평정 척도에서도 우울증이 동반된 공황장애 환자들의 증상 심각도가 더 높은 것으로 나타났다. 반면, 주요우울장애를 동반한 환자들의 심박 변이도가 보다 낮은 경향이 있었지만 두 군사이에 통계적으로 유의한 차이는 없었다. 결 론：본 연구 결과로 주요우울장애를 동반한 공황장애 환자들이 공황장애만을 지닌 환자들에 비해 임상 양상이 심하고 더 많은 고통을 겪는다는 것을 알수 있었다. 그러나 HRV 지표에서는 두 집단간 유의한 차이가 관찰되지 않았다. 향후 더 많은 대상자를 포함한 연구가 시행된다면 주요우울장애의 동반 여부에 따른 자율신경계 기능의 차이에 대해 더 많은 이해가 가능하리라고 기대된다.

• 생물정신의학
• /
• 제2권1호
• /
• pp.70-76
• /
• 1995

A few researchers have reported that major depression may be associated with higher levels of positive acute phase proteins(APPs), such as haptoglobin(Hp), ${\alpha}1$-antitrypsin(${\alpha}1AT$), ceruloplasmin(Cp) and lower levels of negative APPs(visceral proteins), such as albumin(Alb) and transferrin(Tf). Elevated levels of positive APPs and a drop in negative APPs constitute important indicators of immune activation. This study was designed to investigate whether altered serum concentrations of positive APPs and of negative APPs reflect the state of depression. Twenty patients who fulfilled DSM-III-R criteria for major depressive disorder and for dysthymic disorder and twelve normal healthy controls were included. The authors measured positive APPs(Hp, ${\alpha}1AT$, Cp) and negative APPs(Alb, Tf) using rate nephelometry and bromcresol green method. 1) There were significant increases of ${\alpha}1AT$, Cp in major depressed patients as compared with normal controls. Trends towards higher Hp and lower Alb, Tf in major depressed patients were observed. 2) No significant difference of APPs concentrations between dysthymic patients and normal controls was found. 3) Severity of depression(HDRS, BDI score) was related to Hp, Cp, ${\alpha}1AT$ value positively. Our findings are partially compatible with the hypothesis that major depression may be accompanied by acute phase response with higher levels of positive APPs and lower levels of negative APPs.

• 중환자간호학회지
• /
• 제13권3호
• /
• pp.62-74
• /
• 2020

Purpose : This study aimed to investigate the prevalence and risk factors of mental health problems in patients discharged from the intensive care unit (ICU). Methods : This was a secondary analysis study using data from a multicenter prospective cohort of post-ICU patients. We analyzed data of 311 patients enrolled in the primary cohort study who responded to the mental health questionnaire three months after the discharge. Anxiety and depression were measured on the Hospital Anxiety-Depression Scale, and post-traumatic stress disorder (PTSD) was measured on the Posttraumatic Diagnostic Scale. Results : The prevalence of anxiety, depression, and PTSD in patients at three months after ICU discharge were 25.7%, 17.4%, and 18.0%, respectively, and 7.7% of them experienced all three problems. Unemployment (OR=1.99, p=.033) and unplanned ICU admission (OR=2.28, p=.017) were risk factors for depression, while women gender (OR=2.34, p=.009), comorbid diseases (OR=2.88, p=.004), non-surgical ICUs (trauma ICU: OR=7.31, p=.002, medical ICU: OR=3.72, p=.007, neurological ICU: OR=2.95, p=.019) and delirium (OR=2.89, p=.009) were risk factors for PTSD. Conclusion : ICU nurses should proactively monitor risk factors for post-ICU mental health problems. In particular, guidelines on the detection and management of delirium in critically ill patients should be observed.

• 생물정신의학
• /
• 제10권1호
• /
• pp.70-79
• /
• 2003

Object : Currently, the alteration of cytokine system has been known to play an important role in regard to depressive symptom. We focused on the relationship between immunological parameters and clinical improvement in major depressive disorder. Method : Data were collected on 26 patients with major depressive disorder using a 8-week prospective follow-up design. After 8-week treatment period with fluoxetine, patients were classified into a response group and a non-response group according to their psychopathological outcome as evaluated by Hamilton Depression Rating Scale. The differences of the immunological parameters between pre-treatment phase and post-treatment phase were compared among patients. The difference of those was also compared within each phase among them. The relationship between socio-demographic variables, depression, cytokine, mononuclear cells was examined by correlation analysis. Multiple regression analyses were performed to explore the predictors of clinical improvement of major depressive disorder. Result : Pre-treatment levels of IL-$1{\beta}$ in the response group were significantly higher than those in the non-response group. Pre-treatment levels of IL-$1{\beta}$ of all patients and in the response group were positively correlated with pre-treatment monocyte counts. Patients with subsequent remission showed significantly lower IL-6 values at baseline than those with non-response. Post-treatment values of IL-6 did not differ significantly among the patients. The correlation test showed more frequent relations among cytokines and mononuclear cells in the response group than in the non-responder group. Especially, serum level of IL-6 in pre-treatment phase was only significantly correlated with HAMD score after 8-week treatement phase, while other cytokines and mononuclear cells were not. Pretreatment level of IL-6 was of paramount importance in predicting clinical improvement of depressive symptom. Conclusion : The immune system of major depressive disorder patients might dichotomize the patients into subsequent responders and non-responders. Immune system might be of great influence on the clinical improvement of major depressive disorder. The mode of interaction between depression and cellular immune function and the mediators responsible for the cytokine production need to be studied further.

• Journal of Preventive Medicine and Public Health
• /
• 제39권1호
• /
• pp.39-45
• /
• 2006

Objectives: This study estimated the burden of disease especially caused by psychiatric disorders in Korea by using DALY, a composite indicator that was recently developed by the Global Burden of Disease study group. Methods: First, 11 of the major psychiatric disorders in Korea were selected based on the ICD-10. Second, the burden of disease due to premature death was estimated by using YLLs (years of life lost due to premature death). Third, for the calculation of the YLD (years lived with disability), the following parameters were estimated in the formula: the incidence rate, the prevalence rate and the disability weight of each psychiatric disorder. Last, we estimated the DALY of the psychiatric disorders by adding the YLLs and YLDs. Results: The burden of psychiatric disorder per 100,000 people was attributed mainly to unipolar major depression (1,278 person-years), schizophrenia (638 person-years) and alcohol use disorder (287 person-years). For males, schizophrenia (596 person-years) and alcohol use disorder (491 person-years) caused the highest burden. For females, unipolar major depression (1,749 person-years) and schizophrenia (680 person-years) cause the highest burden. As analyzed by gender and age group, alcohol use disorder causes a higher burden than schizophrenia in men aged 40 years and older. For females, unipolar major depression causes the highest burden in all age groups. Conclusions: We found that each of the psychiatric disorders that cause the highest burden is different according to gender and age group. This study's results can provide a rational basis to plan a national health policy regarding the burden of disease caused by psychiatric disorders.

• Clinical Psychopharmacology and Neuroscience
• /
• 제16권4호
• /
• pp.434-448
• /
• 2018

Objective: The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was first published in 2002 through an expert consensus of opinion, and updated in 2006, 2010, and 2014. This study constitutes the fourth revision of the KMAP-BP. Methods: A 50-item questionnaire was used to obtain the consensus of experts regarding pharmacological treatment strategies for various phases of adult bipolar disorder and six items for pediatric bipolar disorder. The review committee included 84 Korean psychiatrists and 43 child and adolescent psychiatry experts. Results: The preferred first-step strategies for acute mania were the combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP), MS monotherapy, and AAP monotherapy. A combination of a MS and an AAP, and AAP monotherapy were preferred for psychotic mania. The first-step strategies for mild to moderate bipolar depression were monotherapy with MS, AAP, or lamotrigine (LMT), and the combination of a MS and an AAP or LMT, or a combination of an AAP and LMT. The combination of two among a MS, AAP, and LMT were preferred for non-psychotic severe depression. A combination of a MS and an AAP or the combination of an AAP with an antidepressant or LMT were the first-line options for psychotic severe depression. Conclusion: The recommendations of the KMAP-BP 2018 have changed from the previous version by reflecting recent developments in pharmacotherapy for bipolar disorder. KMAP-BP 2018 provides clinicians with a wealth of information regarding appropriate strategies for treating patients with bipolar disorder.

• 한국산림과학회지
• /
• 제101권4호
• /
• pp.677-685
• /
• 2012

본 연구의 목적은 숲 환경을 이용한 주요우울장애의 정신사회적 치료 프로그램을 개발하여, 그 효과를 대조군 비교 연구를 통해 확인하는 것이다. 정신과 전문의에 의해 주요우울장애로 진단 받고 현재 정신과 외래에서 항우울제 약물치료 중인 사람들이 연구에 참여하였다. 이들은 각각 네 집단으로 나뉘어 세 집단은 각각 산림에서 시행한 치유 프로그램, 병원에서 시행한 치유 프로그램, 단순 산림욕에 참여하였고, 나머지 한 집단은 프로그램을 시행하지 않고 일반 진료만 받은 대조군이었다. 이들은 모두 프로그램 전후의 우울증상 변화, 생리적 지표 변화를 관찰하기 위해 Hamilton Rating Scales for Depression(HRSD), Montgomery-Asberg Depressin Rating Scales(MADRS), Beck Depression Inventory(BDI), Short Form Health Survey Questionnaire(SF-36), Heart Rate Variability(HRV)검사를 받았다. 연구 결과, 산림치유 프로그램 집단의 HRSD 점수가 대조군에 비해 유의하게 감소하였고, MADRS 점수는 산림치유 프로그램 집단, 병원 프로그램 집단이 대조군에 비해서 유의미한 호전을 보였다. HRSD 7점 이하로 정의되는 관해율은 산림치유 프로그램 집단이 가장 높았다. 또한 SF-36결과, 산림치유 프로그램 집단에서만 건강 상태와 관련된 삶의 질 수준이 유의미하게 증가하였고, Heart Rate Variability(HRV)에서도 생리적 이완감을 나타내는 HF가 유의하게 높아지는 결과를 보였다. 이 결과를 통하여 산림환경을 이용한 심리치료 프로그램을 외래 치료 중인 우울증 환자에게 적용했을 때 우울증 증상 개선에 도움이 됨을 알 수 있었다. 또한 통계적으로 유의하진 않지만, 우울증상 감소와 관해율에 있어서 산림치유 프로그램 집단, 병원 프로그램 집단, 산림욕 집단, 대조군 순으로 좋은 결과를 보였다.